EMEND IV 150 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG
Available from:
MERCK SHARP & DOHME ISRAEL LTD
ATC code:
A04AD12
Pharmaceutical form:
POWDER FOR SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
MERCK SHARP & DOHME B.V, HOLLAND
Therapeutic group:
APREPITANT
Therapeutic indications:
Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
Authorization date:
2011-11-01
